News
11d
Zacks Investment Research on MSNAnalysts Estimate Stoke Therapeutics, Inc. (STOK) to Report a Decline in Earnings: What to Look Out forThe market expects Stoke Therapeutics, Inc. (STOK) to deliver a year-over-year decline in earnings on higher revenues when it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results